|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/605 | |
| A61K 38/26 | |||
| A61P 3/10 |
| (11) | Number of the document | 1294757 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01939252.1 |
| Date of filing the European patent application | 2001-06-01 | |
| (97) | Date of publication of the European application | 2003-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2006-11-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2001/016474 |
| Date | 2001-06-01 |
| (87) | Number | WO 2001/098331 |
| Date | 2001-12-27 |
| (30) | Number | Date | Country code |
| 212171 P | 2000-06-16 | US | |
| 240349 P | 2000-10-13 | US |
| (72) |
GLAESNER, Wolfgang, US
MILLICAN, Rohn, Lee, US
|
| (73) |
ELI LILLY AND COMPANY,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | GLUCAGON-LIKE PEPTIDE-1 ANALOGS |
| GLUCAGON-LIKE PEPTIDE-1 ANALOGS |